Genetics Startup Aims to ‘Make 100 the New 60’
- 10 years ago
J. Craig Venter, the man who helped map the human genome, is at it again. This time, the goal is to add decades onto everybody’s lives.
J. Craig Venter, the man who helped map the human genome, is at it again.
This time, the goal is to better understand aging and age-related diseases and use that information to add decades onto everybody’s lives.
The new company, funded by 70 million dollars in venture capital, is called Human Longevity, Inc.
At the top of its ‘to do’ list is to start sequencing genomes at a rate of 40 thousand per year.
That will be made possible with the help of a 10 million dollar machine, which will also lower the cost of individual analysis to a thousand dollars per subject.
The first mapping of the human genome racked up a tab of 100 million dollars and took 9 months.
In this project, the sequencing is only part of the much bigger picture.
Once the data is collected, it will be combined with the medical records and target biological information of those who participated.
Combined, it’s hoped that enough information will be provided to crack the mystery behind aging and, as their Vice-Chairman said, ‘make 100 the new 60’.
-----------------
J. Craig Venter, the man who helped map the human genome, is at it again.
This time, the goal is to better understand aging and age-related diseases and use that information to add decades onto everybody’s lives.
The new company, funded by 70 million dollars in venture capital, is called Human Longevity, Inc.
At the top of its ‘to do’ list is to start sequencing genomes at a rate of 40 thousand per year.
That will be made possible with the help of a 10 million dollar machine, which will also lower the cost of individual analysis to a thousand dollars per subject.
The first mapping of the human genome racked up a tab of 100 million dollars and took 9 months.
In this project, the sequencing is only part of the much bigger picture.
Once the data is collected, it will be combined with the medical records and target biological information of those who participated.
Combined, it’s hoped that enough information will be provided to crack the mystery behind aging and, as their Vice-Chairman said, ‘make 100 the new 60’.
-----------------